Skip to content

Central effect of acupuncture at Yanglingquan based on acupoint specificity on food picture stimulation paradigm with gallstone disease: a randomized controlled trial.

Correlation and mechanism of Yanglingquan-Danfu-Brain based on the complexity analysis of multi-functional image data MSE

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034368
Enrollment
Unknown
Registered
2020-07-03
Start date
2020-08-20
Completion date
Unknown
Last updated
2020-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gallstone disease

Interventions

Sponsors

Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for gallstone disease set by the EASL in 2016; 2. Aged between 18 and 60 years and right-handed; 3. have not taken any cholagogic drugs within 1 month; 4. not participating in any other clinical trials in the past three months; 5. having signed informed consent.

Exclusion criteria

Exclusion criteria: 1. calculus in bile duct; 2. acute cholecystitis, acute suppurative, gangrenous, incarcerated cholecystitis and perforation of gallbladder with diffuse peritonitis, etc.; 3. with serious complications or primary diseases such as cardiovascular, liver, kidney, endocrine and hematopoietic system; 4. with severe digestive system diseases, such as peptic ulcer, upper gastrointestinal hemorrhage, gastric tumor, Crohn's disease, irritable bowel syndrome, etc; 5. WBC > 12*10^9/L with systemic inflammatory response; 6. having a history of corticosteroid treatment in the past month; 7. having a history of anti-infective drug therapy (excluding cephalosporins) in the past month; 8. with high anxiety and depression (SAS >= 70 or SDS >= 72) and those with mental illness; 9. with obvious headache, migraine, head injury history and obvious pain in other parts; 10. women being in pregnancy or lactation; or 11. having contraindications of MRI scans such as claustrophobia or implanted ferromagnetic metal; 12. with head space occupying disease.

Design outcomes

Primary

MeasureTime frame
task fMRI data;

Secondary

MeasureTime frame
appetite test;Numeric Rating Scale;

Countries

China

Contacts

Public ContactSun Ruirui
sunruirui@cdutcm.edu.cn+86 13882178547

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 22, 2026